Korean J Physiol Pharmacol.  2008 Aug;12(4):155-164. 10.4196/kjpp.2008.12.4.155.

Resveratrol Inhibits Nicotinic Stimulation-Evoked Catecholamine Release from the Adrenal Medulla

• Woo SC
• Na GM
• Lim DY

• KMID: 1838353
• DOI: http://doi.org/10.4196/kjpp.2008.12.4.155

Abstract

Resveratrol has been known to possess various potent cardiovascular effects in animal, but there is little information on its functional effect on the secretion of catecholamines (CA) from the perfused model of the adrenal medulla. Therefore, the aim of the present study was to determine the effect of resveratrol on the CA secretion from the isolated perfused model of the normotensive rat adrenal gland, and to elucidate its mechanism of action. Resveratrol (10~100micrometer) during perfusion into an adrenal vein for 90 min inhibited the CA secretory responses evoked by ACh (5.32 mM), high K+ (a direct membrane-depolarizer, 56 mM), DMPP (a selective neuronal nicotinic Nn receptor agonist, 100micrometer) and McN-A-343 (a selective muscarinic M1 receptor agonist, 100micrometer) in both a time- and dose- dependent fashion. Also, in the presence of resveratrol (30micrometer), the secretory responses of CA evoked by veratridine 8644 (an activator of voltage-dependent Na+ channels, 100micrometer), Bay-K-8644 (a L-type dihydropyridine Ca2+ channel activator, 10micrometer), and cyclopiazonic acid (a cytoplasmic Ca2+ -ATPase inhibitor, 10micrometer) were significantly reduced. In the simultaneous presence of resveratrol (30micrometer) and L-NAME (an inhibitor of NO synthase, 30micrometer), the CA secretory evoked by ACh, high K+, DMPP, McN-A-343, Bay-K-8644 and cyclopiazonic acid were recovered to a considerable extent of the corresponding control secretion compared with the inhibitory effect of resveratrol alone. Interestingly, the amount of nitric oxide (NO) released from the adrenal medulla was greatly increased in comparison to its basal release. Taken together, these experimental results demonstrate that resveratrol can inhibit the CA secretory responses evoked by stimulation of cholinergic nicotinic receptors, as well as by direct membrane-depolarization in the isolated perfused model of the rat adrenal gland. It seems that this inhibitory effect of resveratrol is exerted by inhibiting an influx of both ions through Na+ and Ca2+ channels into the adrenomedullary cells as well as by blocking the release of Ca2+ from the cytoplasmic calcium store, which are mediated at least partly by the increased NO production due to the activation of NO synthase.

Keyword

Resveratrol; Catecholamine secretion; Adrenal medulla; Cholinergic receptors; Nitric oxide

MeSH Terms

(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
Adrenal Glands
Adrenal Medulla
Animals
Calcium
Catecholamines
Cytoplasm
Dihydropyridines
Dimethylphenylpiperazinium Iodide
Indoles
Ions
Neurons
NG-Nitroarginine Methyl Ester
Nitric Oxide
Nitric Oxide Synthase
Perfusion
Rats
Receptor, Muscarinic M1
Receptors, Cholinergic
Receptors, Nicotinic
Stilbenes
Veins
Veratridine
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
Calcium
Catecholamines
Dihydropyridines
Dimethylphenylpiperazinium Iodide
Indoles
Ions
NG-Nitroarginine Methyl Ester
Nitric Oxide
Nitric Oxide Synthase
Receptor, Muscarinic M1
Receptors, Cholinergic
Receptors, Nicotinic
Stilbenes
Veratridine

Figure

• 

  Fig. 1. Dose-dependent effect of resveratrol on the secretory responses of catecholamines (CA) evoked by acetylcholine (upper) and high potassium (lower) from the isolated perfused rat adrenal glands. The CA secretion by a single injection of ACh (5.32×10−3 M) and K+ (5.6×10−2 M) in a volume of 0.05 ml was evoked at 15 min intervals during loading with 10, 30 and 100 μM of resveratrol for 90 min as indicated by the arrow marks, respectively. The numbers in parentheses indicate the number of rat adrenal glands. Vertical bars on the columns represent the standard error of the mean (SEM). Ordinate: the amounts of CA secreted from the adrenal gland (% of control). Abscissa: collection time of perfusate (min). Statistical difference was obtained by comparing the corresponding control (CONTROL) with each concentration- treated group of resveratrol. ACh- and high K+-induced perfusates were collected for 4 minutes, respectively. ∗∗p<0.01. ns: not statistically significant.

• 

  Fig. 2. Dose-dependent effect of resveratrol on the CA secretory responses evoked by DMPP (upper) and McN-A-343 (lower) from the isolated perfused rat adrenal glands. The CA secretion by perfusion of DPPP (10−4 M) and McN-A-343 (10−4 M) for 2 min was induced at 20 and 15 min intervals during loading with 10, 30 and 100 μM of resveratrol for 90 min, respectively. Statistical difference was obtained by comparing the corresponding control (CONTROL) with each concentration- pretreated group of resveratrol. DMPP- and McN-A-343-induced perfusates were collected for 8 and 4 minutes, respectively. Other legends are the same as in Fig. 1. ∗p<0.05, ∗∗p<0.01. ns: not statistically significant.

• 

  Fig. 3. The time-dependent effects of resveratrol on the CA release evoked by Bay-K-8644 (upper) and cyclopiazonic acid (lower) from the rat adrenal glands. Bay-K-8644 (10−5 M) and cyclopiazonic acid (10−5 M) were perfused into an adrenal vein for 4 min at 15 min intervals during loading with resveratrol (30 μM) for 90 min. Other legends are the same as in Fig. 1. ∗p<0.05, ∗∗p<0.01. ns: not statistically significant.

• 

  Fig. 4. Time-course effects of resveratrol on the CA release evoked by veratridine from the rat adrenal glands. Veratridine (10−4 M) was perfused into an adrenal vein for 4 min at 15 min intervals during loading with resveratrol (30 μM) for 90 min. Other legends are the same as in Fig. 1. ∗∗p<0.01.

• 

  Fig. 5. Effect of resveratrol plus L-NAME on the CA secretory responses evoked by acetylcholine (upper) and high potassium (lower) from the perfused rat adrenal glands. The CA secretion by a single injection of ACh (5.32×10−3 M) and K+ (5.6×10−2 M) in a volume of 0.05 ml was evoked at 15 min intervals during simultaneous loading with resveratrol (30 μM) plus L-NAME (30 μM) for 90 min. Statistical difference was obtained by comparing the corresponding control (CONTROL) with resveratrol-treated group or group treated with resveratrol + L-NAME. Other legends are the same as in Fig. 1. ∗p<0.05, ∗∗p<0.01. ns: not statistically significant.

• 

  Fig. 6. Effect of resveratrol plus L-NAME on the CA secretory responses evoked by DMPP (upper) and McN-A-343 (lower) from the perfused rat adrenal glands. The CA secretion by perfusion of DPPP (10−4 M) and McN-A-343 (10−4 M) for 2 min was induced at 20 and 15 min intervals after preloading with resveratrol (30 μM) plus L-NAME (30 μM) for 90 min, respectively. Other legends are the same as in Fig. 1 and 5. ∗∗p<0.01. ns: not statistically significant.

• 

  Fig. 7. Effects of resveratrol plus L-NAME on the CA secretory responses evoked by Bay-K-8644 (upper) and cyclopiazonic acid (lower) from the rat adrenal glands. Bay-K-8644 (10−5 M) and cyclopiazonic acid (10−5 M) were perfused into an adrenal vein for 4 min at 15 min intervals during simultaneous loading with resveratrol (30 μM) for 90 min. Other legends are the same as in Fig. 1 and 5. ∗p<0.05, ∗∗p<0.01. ns: not statistically significant.

• 

  Fig. 8. Comparison of nitric oxide (NO) production before (CONTROL) and after administration of resveratrol in the isolated perfused rat adrenal medulla. Perfusate sample was taken for 8 min after loading the perfusion of resveratrol (100μM) at a rate of 0.31 ml/min. Ordinate: the amounts of NO released from the adrenal medulla (% of control). Abscissa: treatment (before and after resveratrol). Statistical difference was made by comparing the control with resveratrol-treated group. ∗∗p<0.01.

Reference

Andriambeloson E., Kleschyov AL., Muller B., Beretz A., Stoclet JC., Andriantsitohaina R. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol. 120:1053–1058. 1997.

Andriambeloson E., Magnier C., Haan-Archipoff G., Lobstein A., Anton R., Beretz A., Stoclet JC., Andriantsitohaina R. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr. 128:2324–2333. 1998.

Andriambeloson E., Stoclet JC., Andriantsitohaina R. Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol. 33:248–254. 1999.

Anton AH., Sayre DF. A study of the factors affecting the aluminum oxide trihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 138:360–375. 1962.

Bernatova I., Pecháòová O., Babál P., Kyselá S., Stvrtina S., Andriantsitohaina R. Wine polyphenols improve cardiovascular remodelling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol. 282:H942–H948. 2002.

Breslow MJ., Tobin JR., Bredt DS., Ferris CD., Snyder SH., Traystman RJ. Nitric oxide as a regulator of adrenal blood flow. Am J Physiol. 264:H464–H469. 1993.

Breslow MJ., Tobin JR., Bredt DS., Ferris CD., Snyder SH., Traystman RJ. Role of nitric oxide in adrenal medullary vasodilation during catecholamine secretion. Eur J Pharmacol. 210:105–106. 1992.

Burgoyne RD. Mechanism of secretion from adrenal chromaffin cells. Biochem Biophys Acta. 779:201–216. 1984.

Celotti E., Ferrarini R., Zironi R., Conte LS. Resveratrol content of some wines obtained from dried Valpolicella grapes: recioto and Amarone. J Chromatogr A. 730:47–52. 1996.

Challiss RA., Jones JA., Owen PJ., Boarder MR. Changes in inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate mass accumulations in cultured adrenal chromaffin cells in response to bradykinin and histamine. J Neurochem. 56:1083–1086. 1991.

Cheek TR., O'Sullivan AJ., Moreton RB., Berridge MJ., Burgoyne RD. Spatial localization of the stimulus-induced rise in cytosolic Ca²⁺ in bovine adrenal chromaffin cells: Distinct nicotinic and muscarinic patterns. FEBS Lett. 247:429–434. 1989.

Chen CK., Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol. 27:363–366. 1996.

Demrow HS., Slane PR. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 91:1182–1188. 1995.

Diebolt M., Bucher B., Andriantsitohaina R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension. 38:159–165. 2001.

Fisher SK., Holz RW., Agranoff BW. Muscarinic receptors in chromaffin cell culture mediate enhanced phospholipid labeling but not catecholamine secretion. J Neurochem. 37:491–487. 1981.

Fitzpatrick DF., Fleming RC., Bing B., Maggi DA., O'Malley R. Isolation and characterization of endothelium-dependent vaso-relaxing compounds from grape seeds. J Agric Food Chem. 48:6384–6390. 2000.

Fitzpatrick DF., Hirschfield SL., Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol. 265:H77–H78. 1993.

Fitzpatrick DF., Hirschfield SL., Ricci T., Jantzen P., Coffey RG. Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol. 26:90–95. 1995.

Flesch M., Schwarz A., Bolun M. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol. 275:H1183–H1190. 1998.

Frankel EN., Waterhouse AL., Kinsella JE. Inhibition of human DL oxidation by resveratrol. Lancet. 341:1103–1104. 1993.

Freedman JE., Li L., Sauter R., Keaney JF Jr. Alpha-Tocopherol and protein kinase C inhibition enhance platelet-derived nitric oxide release. FASEB J. 14(15):2377–2379. 2000.

Garcia AG., Sala F., Reig JA., Viniegra S., Frias J., Fonteriz R., Gandia L. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature. 309:69–71. 1984.

Gareri P., Falconi U., De Fazio P., De Sarro G. Conventional and new antidepressant drugs in the elderly. Prog Neurobiol. 61:353–396. 2000.

German JB., Walzem RL. The health benefits of wine. Annu Rev Nutr. 20:561–593. 2000.

Goeger DE., Riley RT. Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on Ca²⁺ binding and Ca²⁺ permeability. Biochem Pharmacol. 38:3995–4003. 1989.

Hammer R., Giachetti A. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci. 31:2992–2998. 1982.

Ilno M. Calcium-induced calcium release mechanism in guinea pig taenia caeci. J Gen Physiol. 94:363–383. 1989.

Jager U., Nguyen-Duong H. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries. Arzneimitlelforschung. 49:207–211. 1999.

Kidokoro Y., Ritchie AK. Chromaffin cell action potentials and their possible role in adrenaline secretion from rat adrenal medulla. J Physiol. 307:199–216. 1980.

Kilpatrick DL., Slepetis RJ., Corcoran JJ., Kirshner N. Calcium uptake and catecholamine secretion by cultured bovine adrenal medulla cells. J Neurochem. 38:427–435. 1982.

Kilpatrick DL., Slepetis RJ., Kirshner N. Ion channels and membrane potential in stimulus-secretion coupling in adrenal medulla cells. J Neurochem. 36:1245–1255. 1981.

Knight DE., Kesteven NT. Evoked transient intracellular free Ca²⁺ changes and secretion in isolated bovine adrenal medullary cells. Proc R Soc Lond Biol Sci. 218:177–199. 1983.

Leikert JF., Räthel TR., Wohlfart PV., Cheynier V., Vollmar AM., Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide release from endothelial cells. Circulation. 106:1614–1617. 2002.

Lim DY., Hwang DH. Studies on secretion of catecholamines evoked by DMPP and McN-A-343 in the rat adrenal gland. Korean J Pharmacol. 27:53–67. 1991.

Lim DY., Kim CD., Ahn KW. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res. 15:115–125. 1992.

Marley PD., McLeod J., Anderson C., Thomson KA. Nerves containing nitric oxide synthase and their possible function in the control of catecholamine secretion in the bovine adrenal medulla. J Auton Nerv Syst. 54:184–194. 1995.

Martin S., Andriambeloson E., Takeda K., Andriantsitohaina R. Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Br J Pharmacol. 135:1579–1587. 2002.

Mizutani K., Ikeda K., Kawai Y., Yamori Y. Extract of wine phenolics improves aortic biomechanical properties in stroke-prone spontaneously hypertensive rats (SHRSP). J Nutr Sci Vitaminol. 45:95–106. 1999.

Naderali EK., Doyle PJ., Wlliams G. Resveratrol induces vaso-relaxation of mesenteric and uterine ateries from female guinea-pigs. Clin Sci. 98:537–543. 2000.

Naderali EK., Smith SL., Doyle PJ., Wlliams G. The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats. Clin Sci. 100:55–60. 2001.

Oka M., Isosaki M., Yanagihara N. Isolated bovine adrenal medullary cells: studies on regulation of catecholamine synthesis and release. Usdin E, Kopin IJ, Brachas J, editors. eds,. Catecholamines: Basic and Clinical frontiers. Pergamon Press;Oxford: p. p. 70–72. 1979.

Orsini F., Pelizzoni F., Verotta L., Aburjai T. Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-b-D-Glucopyranoside and related compounds. J Nat Prod. 60:1082–1087. 1997.

Oset-Gasque MJ., Parramon M., Hortelano S., Bosca L., Gonzalez MP. Nitric oxide implication in the control of neurosecretion by chromaffin cells. J Neurochem. 63:1693–1700. 1994.

O'Sullivan AJ., Burgoyne RD. Cyclic GMP regulates nicotine-induced secretion from cultured bovine adrenal chromaffin cells: effects of 8-bromo-cyclic GMP, atrial natriuretic peptide, and nitroprusside (nitric oxide). J Neurochem. 54:1805–1808. 1990.

Pace-Asciak CR., Hahn SE., Diamandis EP., Soleas G., Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implication for protection against coronary heart disease. Clin Chim Acta. 235:207–219. 1995.

Palacios M., Knowles RG., Palmer RM., Moncada S. Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem Biophys Res Commun. 165:802–809. 1989.

Rakici O., Kiziltepe U., Coskun B., Aslamaci S., Akar F. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int J Cardiol. 105:209–115. 2005.

Renaud S., de Lorgeril M. Wine alcohol, platelet and the French paradox for coronary heart disease. Lancet. 339:1523–1526. 1992.

Rodriguez-Pascual F., Miras-Portugal MT., Torres M. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase. Mol Pharmacol. 49:1058–1070. 1996.

Rotondo S., Rajtar G., Manarinis S. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol. 123:1691–1699. 1998.

Sato M., Suzuki Y., Okuda T., Yokotsuka K. Content of resveratrol, piceid and their isomers in commercially available wines made from grapes cultivated in Japan. Biosci Biotechnol Biochem. 61:1800–1805. 1997.

Schramm M., Thomas G., Towart R., Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca²⁺ channels. Nature. 303:535–537. 1983.

Schwarz PM., Rodriguez-Pascual F., Koesling D., Torres M., Forstermann U. Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells. Neuroscience. 82:255–265. 1998.

Seidler NW., Jona I., Vegh N., Martonosi A. Cyclopiazonic acid is a specific inhibitor of the Ca²⁺-ATPase of sarcoplasmic reticulum. J Biol Chem. 264:17816–17823. 1989.

Slotkin TA., Whitmore WL., Dew KL., Kilts CD. Uptake of serotonin into rat platelets and synaptosomes: comparative structure-activity relationships, energetics and evaluation of the effects of acute and chronic nortriptyline administration. Brain Res Bull. 17:67–73. 1986.

Suzuki M., Muraki K., Imaizumi Y., Watanabe M. Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca²⁺-pump, reduces Ca²⁺-dependent K⁺ currents in guinea-pig smooth muscle cells. Br J Pharmacol. 107:134–140. 1992.

Tallarida RJ., Murray RB. Manual of pharmacologic calculation with computer programs. 2nd ed.Speringer-Verlag;New York: p. p. 132. 1987.

To SE., Zepf RA., Woods AG. The symptoms, neurobiology, and current pharmacological treatment of depression. J Neurosci Nurs. 37:102–107. 2005.

Torres M., Ceballos G., Rubio R. Possible role of nitric oxide in catecholamine secretion by chromaffin cells in the presence and absence of cultured endothelial cells. J Neurochem. 63:988–996. 1994.

Uchiyama Y., Morita K., Kitayama S., Suemitsu T., Minami N., Miyasako T., Dohi T. Possible involvement of nitric oxide in acetylcholine-induced increase of intracellular Ca²⁺ concentration and catecholamine release in bovine adrenal chromaffin cells. Jpn J Pharmacol. 65:73–77. 1994.

Uenobe F., Nakamura S., Miyazawa M. Antimutagenic effects of resveratrol against Trp-P-1. Mutat Res. 373:197–200. 1997.

Uyama Y., Imaizumi Y., Watanabe M. Effects of cyclopiazonic acid, a novel Ca²⁺-ATPase inhibitor on contractile responses in skinned ileal smooth muscle. Br J Pharmacol. 106:208–214. 1992.

Wada A., Takara H., Izumi F., Kobayashi H., Yanagihara N. Influx of ²²Na through acetylcholine receptor-associated Na channels: relationship between ²²Na influx, ⁴⁵Ca influx and secretion of catecholamines in cultured bovine adrenal medullary cells. Neuroscience. 15:283–292. 1985.

Wakade AR. Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J Physiol. 313:463–480. 1981.

Wakade AR., Wakade TD. Contribution of nicotinic and muscarinic receptors in the secretion of catecholamines evoked by endogenous and exogenous acetylcholine. Neuroscience. 10:973–978. 1983.

Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., Forstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation. 106:1652–1658. 2002.

Yanagihara N., Isosaki M., Ohuchi T., Oka M. Muscarinic receptor-mediated increase in cyclic GMP level in isolated bovine adrenal medullary cells. FEBS Lett. 105:296–298. 1979.

Yanez M., Fraiz N., Cano E., Orallo F. Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem Biophys Res Commun. 344:688–695. 2006.

Zenebe W., Pechaoova O., Andriantsitohaina R. Red wine poly-phenols induce vasorelaxation by increased nitric oxide bioactivity. Physiol Res. 52:425–432. 2003.

Zhou CX., Kong LD., Ye WC., Cheng CH., Tan RX. Inhibition of xanthine and monoamine oxidases by stilbenoids from Veratrum taliense. Planta Med. 67:158–161. 2001.